Answers are grounded in this paper and cite their sources.
We assessed the clinical effectiveness of cefiderocol (CFDC) in comparison with colistin (COL) for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections (BSI).
No takes yet. Share an insight, caveat, or question.
Oliva et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: